56th Annual Meeting
Tentative Program Schedule
Please note that this schedule is subject to change. The Program Book distributed at the Annual Meeting will have final information on dates, times, and speakers for each presentation.
Home | Search | Browse by Day or Program | Author Index


New Research Poster Presentation 1.34
Relationship Between Atomoxetine Plasma Concentration, Treatment Response, and Tolerability in ADHD and Comorbid Oppositional Defiant Disorder

Wednesday, October 29, 2008: 9:15 AM
River Exhibition Hall (Sheraton Chicago Hotel & Towers)
Philip Hazell, FRANZCP, MBChB, Ph.D., Discipline of Psychological Medicine, Concord Clinical School, University of Sydney, Concord West, NSW, Australia
Katja Becker, M.D., Central Institute of Mental Health, Mannheim, Germany
Leannart von Wendt, Hyks Lasten ja Nuorten Sairaal, Helsinki, Finland
Paula T. Trzepacz, M.D., Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN
Linda Tabas, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN
Leslie M. Schuh, Ph.D., Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN
Jennifer Witcher, Ph.D., Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN
Amanda Long, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN
George Ponsler, M.S., Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN
Yoko Tanaka, Ph.D., Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN
Ralf W. Dittmann, M.D., Ph.D., Lilly Deutschland and University of Hamburg, Bad Homburg, Germany
See more of: New Research Poster Session 1
See more of: New Research Poster